The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine
Open accessAbstract
Dexmedetomidine is an α2-adrenoceptor agonist with sedative, anxiolytic, sympatholytic, and analgesic-sparing effects, and minimal depression of respiratory function. It is potent and highly selective for α2-receptors with an α2:α1 ratio of 1620:1. Hemodynamic effects, which include transient hypertension, bradycardia, and hypotension, result from the drug’s peripheral vasoconstrictive and sympatholytic properties. Dexmedetomidine exerts its hypnotic action through activation of central pre- and postsynaptic α2-receptors in the locus coeruleus, thereby inducting a state of unconsciousness similar to natural sleep, with the unique aspect that patients remain easily rousable and cooperative. Dexmedetomidine is rapidly distributed and is mainly hepatically metabolized into inactive metabolites by glucuronidation and hydroxylation. A high inter-individual variability in dexmedetomidine pharmacokinetics has been described, especially in the intensive care unit population. In recent years, multiple pharmacokinetic non-compartmental analyses as well as population pharmacokinetic studies have been performed. Body size, hepatic impairment, and presumably plasma albumin and cardiac output have a significant impact on dexmedetomidine pharmacokinetics. Results regarding other covariates remain inconclusive and warrant further research. Although initially approved for intravenous use for up to 24 h in the adult intensive care unit population only, applications of dexmedetomidine in clinical practice have been widened over the past few years. Procedural sedation with dexmedetomidine was additionally approved by the US Food and Drug Administration in 2003 and dexmedetomidine has appeared useful in multiple off-label applications such as pediatric sedation, intranasal or buccal administration, and use as an adjuvant to local analgesia techniques.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
Kearns, G. L., Abdel-Rahman, S. M., Alander, S. W., Blowey, D. L., Leeder, J. S., & Kauffman, R. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035092 · Cited by 2,421
Riker, R. R. (2009) · JAMA · doi:10.1001/jama.2009.56 · Cited by 1,672
Pandharipande, P. P., Pun, B. T., Herr, D. L., Maze, M., Girard, T. D., Miller, R. R., Shintani, A. K., Thompson, J. L., Jackson, J. C., Deppen, S. A., et al. (2007) · JAMA · doi:10.1001/jama.298.22.2644 · Cited by 1,451
The Effects of Increasing Plasma Concentrations of Dexmedetomidine in Humans
Ebert, T. J., Hall, J. E., Barney, J. A., Uhrich, T. D., & Colinco, M. D. (2000) · Anesthesiology · doi:10.1097/00000542-200008000-00016 · Cited by 1,388
Sedative, Amnestic, and Analgesic Properties of Small-Dose Dexmedetomidine Infusions
Hall, J. E., Uhrich, T. D., Barney, J. A., Arain, S. R., & Ebert, T. J. (2000) · Anesthesia & Analgesia · doi:10.1097/00000539-200003000-00035 · Cited by 1,069
Jakob, S. M. (2012) · JAMA · doi:10.1001/jama.2012.304 · Cited by 980
Nelson, L. E., Lu, J., Guo, T., Saper, C. B., Franks, N. P., & Maze, M. (2003) · Anesthesiology · doi:10.1097/00000542-200302000-00024 · Cited by 854
Changes in plasma protein binding have little clinical relevance
Benet, L. Z., & Hoener, B. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.121829 · Cited by 825
Effects of Intravenous Dexmedetomidine in Humans: II. Hemodynamic Changes
Bloor, B. C., Ward, D. S., Belleville, J. P., & Maze, M. (1992) · Anesthesiology · doi:10.1097/00000542-199212000-00014 · Cited by 729
Virtanen, R., Savola, J.-M., Saano, V., & Nyman, L. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90744-3 · Cited by 701
Effects of Intravenous Dexmedetomidine in Humans: I. Sedation, Ventilation, and Metabolic Rate
Belleville, J. P., Ward, D. S., Bloor, B. C., & Maze, M. (1992) · Anesthesiology · doi:10.1097/00000542-199212000-00013 · Cited by 556
Blaudszun, G., Lysakowski, C., Elia, N., & Tramèr, M. R. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31825681cb · Cited by 554
Central Hypotensive Effects of the α 2a -Adrenergic Receptor Subtype
MacMillan, L. B., Hein, L., Smith, M. S., Piascik, M. T., & Limbird, L. E. (1996) · Science · doi:10.1126/science.273.5276.801 · Cited by 489
Hsu, Y.-W., Cortinez, L. I., Robertson, K. M., Keifer, J. C., Sum-Ping, S. T., Moretti, E. W., Young, C. C., Wright, D. R., MacLeod, D. B., & Somma, J. (2004) · Anesthesiology · doi:10.1097/00000542-200411000-00005 · Cited by 462
Dexmedetomidine and the Reduction of Postoperative Delirium after Cardiac Surgery
Maldonado, J. R., Wysong, A., van der Starre, P. J. A., Block, T., Miller, C., & Reitz, B. A. (2009) · Psychosomatics · doi:10.1176/appi.psy.50.3.206 · Cited by 460
Dexmedetomidine Attenuates Isoflurane-induced Neurocognitive Impairment in Neonatal Rats
Sanders, R. D., Xu, J., Shu, Y., Januszewski, A., Halder, S., Fidalgo, A., Sun, P., Hossain, M., Ma, D., & Maze, M. (2009) · Anesthesiology · doi:10.1097/aln.0b013e31819daedd · Cited by 433
Kronenberg, R. S., & Drage, C. W. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107363 · Cited by 394
A Hypnotic Response to Dexmedetomidine, an α2 Agonist, Is Mediated in the Locus Coerüleus in Rats
Correa-Sales, C., Rabin, B. C., & Maze, M. (1992) · Anesthesiology · doi:10.1097/00000542-199206000-00013 · Cited by 394
Glucuronidation in Humans: Pharmacogenetic and Developmental Aspects
de Wildt, S. N., Kearns, G. L., Leeder, J. S., & van den Anker, J. N. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00005 · Cited by 393
Estimation of the aqueous solubility I: Application to organic nonelectrolytes
Jain, N., & Yalkowsky, S. H. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200102)90:2<172::aid-jps8>3.0.co;2-j · Cited by 375
Bioavailability of dexmedetomidine after extravascular doses in healthy subjects
Anttila, M., Penttilä, J., Helminen, A., Vuorilehto, L., & Scheinin, H. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01944.x · Cited by 300
Developmental aspects of human hepatic drug glucuronidation in young children and adults
Strassburg, C. P., Strassburg, A., Kneip, S., Barut, A., Tukey, R. H., Rodeck, B., & Manns, M. P. (2002) · Gut · doi:10.1136/gut.50.2.259 · Cited by 288
Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice
Gu, J., Sun, P., Zhao, H., Watts, H. R., Sanders, R. D., Terrando, N., Xia, P., Maze, M., & Ma, D. (2011) · Critical Care · doi:10.1186/cc10283 · Cited by 276
Neuronal ensembles sufficient for recovery sleep and the sedative actions of α2 adrenergic agonists
Zhang, Z., Ferretti, V., Güntan, İ., Moro, A., Steinberg, E. A., Ye, Z., Zecharia, A. Y., Yu, X., Vyssotski, A. L., Brickley, S. G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3957 · Cited by 275
Engelhard, K., Werner, C., Eberspächer, E., Bachl, M., Blobner, M., Hildt, E., Hutzler, P., & Kochs, E. (2003) · Anesthesia & Analgesia · doi:10.1097/00000539-200302000-00041 · Cited by 252
Talke, P., Tayefeh, F., Sessler, D. I., Jeffrey, R., Noursalehi, M., & Richardson, C. (1997) · Anesthesiology · doi:10.1097/00000542-199710000-00017 · Cited by 247
Reduction of the Minimum Alveolar Concentration of Isoflurane by Dexmedetomidine
Aantaa, R., Jaakola, M.-L., Kallio, A., & Kanto, J. (1997) · Anesthesiology · doi:10.1097/00000542-199705000-00008 · Cited by 237
Aho, M., Lehtinen, A.-M., Erkola, O., Kallio, A., & Korttila, K. (1991) · Anesthesiology · doi:10.1097/00000542-199106000-00005 · Cited by 228
Bioavailability of dexmedetomidine after intranasal administration
Iirola, T., Vilo, S., Manner, T., Aantaa, R., Lahtinen, M., Scheinin, M., & Olkkola, K. T. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1002-y · Cited by 224
Segal, I. S., Vickery, R. G., Walton, J. K., Doze, V. A., & Maze, M. (1988) · Anesthesiology · doi:10.1097/00000542-198812000-00004 · Cited by 219
An Updated Focused Review of Dexmedetomidine in Adults
Gerlach, A. T., Murphy, C. V., & Dasta, J. F. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m310 · Cited by 200
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery
Feld, J. M., Hoffman, W. E., Stechert, M. M., Hoffman, I. W., & Ananda, R. C. (2006) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2005.05.009 · Cited by 199
Doze, V. A., Chen, B.-X., & Maze, M. (1989) · Anesthesiology · doi:10.1097/00000542-198907000-00014 · Cited by 194
Meta-Analysis of Factors Which Influence Delirium Following Cardiac Surgery
Lin, Y., Chen, J., & Wang, Z. (2012) · Journal of Cardiac Surgery · doi:10.1111/j.1540-8191.2012.01472.x · Cited by 192
Systemically Administered α2-Agonist-induced Peripheral Vasoconstriction in Humans
Talke, P., Lobo, E., & Brown, R. (2003) · Anesthesiology · doi:10.1097/00000542-200307000-00014 · Cited by 190
Non-shivering Thermogenesis and Brown Adipose Tissue in the Human New-born Infant
DAWKINS, M. J. R., & SCOPES, J. W. (1965) · Nature · doi:10.1038/206201b0 · Cited by 187
A General Purpose Pharmacokinetic Model for Propofol
Eleveld, D. J., Proost, J. H., Cortínez, L. I., Absalom, A. R., & Struys, M. M. R. F. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000165 · Cited by 182
Self-citationZhu, Y.-M., Wang, C.-C., Chen, L., Qian, L.-B., Ma, L.-L., Yu, J., Zhu, M.-H., Wen, C.-Y., Yu, L.-N., & Yan, M. (2013) · Brain Research · doi:10.1016/j.brainres.2012.11.047 · Cited by 176
Abdallah, F. W., Dwyer, T., Chan, V. W. S., Niazi, A. U., Ogilvie-Harris, D. J., Oldfield, S., Patel, R., Oh, J., & Brull, R. (2016) · Anesthesiology · doi:10.1097/aln.0000000000000983 · Cited by 171
Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients
Chen, K., Lü, Z., Yi, X., Cai, Y., Chen, Y., & Pan, S. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010269.pub2 · Cited by 168
Dexmedetomidine pharmacokinetics in pediatric intensive care – a pooled analysis
POTTS, A. L., ANDERSON, B. J., WARMAN, G. R., LERMAN, J., DIAZ, S. M., & VILO, S. (2009) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2009.03133.x · Cited by 165
Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients
Iirola, T., Ihmsen, H., Laitio, R. M., Kentala, E., Aantaa, R., Kurvinen, J., Scheinin, M., Schwilden, H., Schüttler, J., & Olkkola, K. T. (2012) · British Journal of Anaesthesia · doi:10.1093/bja/aer441 · Cited by 154
Influence of Race or Ethnicity on Pharmacokinetics of Drugs
Johnson, J. A. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9702168 · Cited by 142
Peden, C. J., Cloote, A. H., Stratford, N., & Roberts, C. P. (2001) · Anaesthesia · doi:10.1046/j.1365-2044.2001.01553.x · Cited by 132
Influence of Cardiac Output on Dexmedetomidine Pharmacokinetics
Dutta, S., Lal, R., Karol, M. D., Cohen, T., & Ebert, T. J. (2000) · Journal of Pharmaceutical Sciences · Cited by 121
Intramuscular Dexmedetomidine as Premedication for General Anesthesia
Scheinin, H., Jaakola, M.-L., Sjövall, S., Ali‐Melkkilä, T., Kaukinen, S., Turunen, J., & Kanto, J. (1993) · Anesthesiology · doi:10.1097/00000542-199306000-00008 · Cited by 118
Perioperative dexmedetomidine for acute pain after abdominal surgery in adults
Lundorf, L. J., Nedergaard, H. K., & Møller, A. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010358.pub2 · Cited by 109
Postoperative Pharmacokinetics and Sympatholytic Effects of Dexmedetomidine
Talke, P. O., Richardson, C. A., Scheinin, M., & Fisher, D. M. (1997) · Anesthesia & Analgesia · doi:10.1097/00000539-199711000-00033 · Cited by 108
Surendar, M. N., Pandey, R. K., Saksena, A., Kumar, R., & Chandra, G. (2014) · Journal of Clinical Pediatric Dentistry · doi:10.17796/jcpd.38.3.l828585807482966 · Cited by 108
Hannivoort, L. N., Eleveld, D. J., Proost, J. H., Reyntjens, K. M. E. M., Absalom, A. R., Vereecke, H. E. M., & Struys, M. M. R. F. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000740 · Cited by 102
Self-citationPharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients
Iirola, T., Aantaa, R., Laitio, R. M., Kentala, E., Lahtinen, M., Wighton, A., Garratt, C., Ahtola-Sätilä, T., & Olkkola, K. T. (2011) · Critical Care · doi:10.1186/cc10518 · Cited by 96
Effect of Systemic Medetomidine, an Alpha2 Adrenoceptor Agonist, on Experimental Pain in Humans
Kauppila, T., Kemppainen, P., Tanila, H., & Pertovaara, A. (1991) · Anesthesiology · doi:10.1097/00000542-199101000-00002 · Cited by 95
Intranasal Dexmedetomidine for Sedation for Pediatric Computed Tomography Imaging
Filho, E. M., Robinson, F., de Carvalho, W. B., et al. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.01.036 · Cited by 92
Riquelme, J. A., Westermeier, F., Hall, A. R., Vicencio, J. M., Pedrozo, Z., Ibacache, M. E., Fuenzalida, B., Sobrevía, L., Davidson, S. M., Yellon, D. M., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.004 · Cited by 89
Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass.
Bakhamees, H., EL-Halafawy, Y. M., El‐Kerdawy, H., Gouda, N. M., & Al-Temyatt, S. (2007) · PubMed · Cited by 85
Talke, P. O., & Bickler, P. E. (1996) · Anesthesiology · doi:10.1097/00000542-199609000-00014 · Cited by 84
Dexmedetomidine preconditioning ameliorates kidney ischemia‐reperfusion injury
Lempiäinen, J., Finckenberg, P., Mervaala, E. E., Storvik, M., Kaivola, J., Lindstedt, K. A., Levijoki, J. M., & Mervaala, E. M. A. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.45 · Cited by 80
Aantaa, R., Jaakola, M.-L., Kallio, A., Kanto, J., Scheinin, M., & Vuorinen, J. A. (1991) · British Journal of Anaesthesia · doi:10.1093/bja/67.4.402 · Cited by 73
Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery
Su, F., Gastonguay, M. R., Nicolson, S. C., DiLiberto, M. A., Ocampo-Pelland, A. S., & Zuppa, A. F. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000869 · Cited by 72
Lodenius, Å., Ebberyd, A., Cedborg, A. I. H., Hagel, E., Mkrtchian, S., Christensson, E., Ullman, J., Scheinin, M., Eriksson, L. I., & Fagerlund, M. J. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001236 · Cited by 72
Population Pharmacokinetics of Dexmedetomidine in Infants After Open Heart Surgery
Su, F., Nicolson, S. C., Gastonguay, M. R., Barrett, J. S., Adamson, P. C., Kang, D. S., Godinez, R. I., & Zuppa, A. F. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181d783c8 · Cited by 70
Yoo, H., Iirola, T., Vilo, S., Manner, T., Aantaa, R., Lahtinen, M., Scheinin, M., Olkkola, K. T., & Jusko, W. J. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1913-0 · Cited by 69
Yao, Y., Qian, B., Lin, Y., Wu, W., Ye, H., & Chen, Y. (2014) · Pediatric Anesthesia · doi:10.1111/pan.12574 · Cited by 68
Dexmedetomidine pharmacokinetics in the obese
Cortínez, L. I., Anderson, B. J., Holford, N. H. G., Puga, V. A., de la Fuente, N., Auad, H., Solari, S., Allende, F. A., & Ibacache, M. E. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1948-2 · Cited by 66
Karhuvaara, S., Kallio, A., Scheinin, M., Anttila, M., Salonen, J. S., & Scheinin, H. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03748.x · Cited by 62
Dholakia, C., Beverstein, G., Garren, M. J., Nemergut, C., Boncyk, J. C., & Gould, J. C. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0290-0 · Cited by 55
Interpatient Variability in Dexmedetomidine Response: A Survey of the Literature
Holliday, S. F., Kane‐Gill, S. L., Empey, P. E., Buckley, M. S., & Smithburger, P. L. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/805013 · Cited by 50
Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients
Välitalo, P. A. J., Ahtola-Sätilä, T., Wighton, A., Sarapohja, T., Pohjanjousi, P., & Garratt, C. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-013-0101-1 · Cited by 46
Kurnik, D., Muszkat, M., Sofowora, G. G., Friedman, E. A., Dupont, W. D., Scheinin, M., Wood, A. J. J., & Stein, C. M. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.098939 · Cited by 45
CYP2A6 genetic variation and dexmedetomidine disposition
Kohli, U., Pandharipande, P. P., Muszkat, M., Sofowora, G. G., Friedman, E. A., Scheinin, M., Wood, A. J. J., Ely, E. W., Tyndale, R. F., Choi, L., et al. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1208-z · Cited by 44
Kim, D. J., Kim, S. H., So, K. Y., & Jung, K. T. (2015) · BMC Anesthesiology · doi:10.1186/s12871-015-0127-4 · Cited by 39
Zhang, X., Bai, X., Zhang, Q., Wang, X.-K., & Lu, L. (2013) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2013.06.202 · Cited by 32
Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
Doze, V. A., Bx, C., Li, Z., & Maze, M. (1989) · PubMed · Cited by 27
Occurrence and Predictors of Dexmedetomidine Infusion Intolerance and Failure
Pennington, B. R. T., Arnold, H. M., Micek, S. T., & Kollef, M. H. (2012) · Hospital Practice · doi:10.3810/hp.2012.02.959 · Cited by 24
Patient Predictors of Dexmedetomidine Effectiveness for Sedation in Intensive Care Units
Smithburger, P. L., Smith, R. B., Kane‐Gill, S. L., & Empey, P. E. (2014) · American Journal of Critical Care · doi:10.4037/ajcc2014678 · Cited by 22
Jang, Y., Kim, Y. C., Yoon, H., Jeon, Y.-T., Hwang, J., Kim, E., & Park, H. (2014) · Journal of Anesthesia · doi:10.1007/s00540-014-1949-9 · Cited by 20
Zhang, T., Deng, Y., He, P., He, Z., & Wang, X. (2015) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2015.06.002 · Cited by 17
Yao, Y., Qian, B., Chen, Y., et al. (2014) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2013.12.012 · Cited by 11
Cited by
The glymphatic system: implications for drugs for central nervous system diseases
Lohela, T. J., Lilius, T. O., & Nedergaard, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00500-9 · Cited by 254
Pediatric Delirium: Recognition, Management, and Outcome
Turkel, S. B. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0851-1 · Cited by 58
Zhang, Q., Liu, X.-M., Hu, Q., Liu, Z.-R., Liu, Z.-Y., Zhang, H.-G., Huang, Y.-L., Chen, Q.-H., Wang, W.-X., & Zhang, X.-K. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03027-6 · Cited by 52
A 2023 update on the advancements in the treatment of agitation in Alzheimer’s disease
Lee, D., Clark, E. D., Antonsdottir, I. M., & Porsteinsson, A. P. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2195539 · Cited by 28
Induction and maintenance of procedural sedation in adults: focus on remimazolam injection
Chen, W., Chen, S., & Huang, Y. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1901575 · Cited by 25
“Dexmedetomidine, which is a selective alpha 2-agonist, has much higher specificity for alpha 2-adrenoceptor than clonidine [46].”
Background
Metadata
- Authors
- Weerink, M. A. S., Struys, M. M. R. F., Hannivoort, L. N., Barends, C. R. M., Absalom, A. R., & Colin, P.
- Venue
- Clinical Pharmacokinetics
- Published
- 2017-01-19
- Volume
- 56
- Issue
- 8
- Pages
- 893-913
- ISSN
- 0312-5963 (ISSN-L)
- 1179-1926
- OpenAlex
- W2576234460
- Cited by
- 1,208
- References
- 78
- FWCI
- 81.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.